Drug Abuse Sciences

About Drug Abuse Sciences

DrugAbuse Sciences, Inc. (DAS) is a private specialty pharmaceutical company headquartered in California, with a wholly owned subsidiary in France. Founded in 1994, DAS is dedicated to the discovery, development, and commercialization of medications specifically designed to treat alcohol and substance abuse and dependence. The company operates in the healthcare sector, focusing on one of the most pressing health issues in the U.S. and Europe—substance abuse. DAS serves a diverse clientele, including individuals suffering from alcohol abuse, alcoholism, and dependence on substances such as heroin, cocaine, and methamphetamine. The company's business model revolves around developing a comprehensive portfolio of products and services dedicated to addiction medicine. Revenue is primarily generated through the commercialization of these medications, which are sold to healthcare providers, clinics, and rehabilitation centers. By focusing solely on addiction medicine, DAS aims to fill a critical gap in the pharmaceutical market, offering specialized solutions that address the unique challenges of substance abuse treatment.